Niva Bupa Health Insurance Company Ltd
Niva Bupa Health Insurance Company Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Overall growth in Q3 was 31%, and 26% for the first 9 months, indicating strong upward momentum. The company targets a Return on Equity (ROE) in the high teens within the next two financial years, indicating growth in profitability.
From Niva Bupa Health Insurance Company Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Overall growth in Q3 was 31%, and 26% for the first 9 months, indicating strong upward momentum.
- New business growth was particularly robust at 46% in Q3 and 30% YTD, driving market share gain from 9.6% to 10.2%.
- Key channels show strong performance: agency grew 43% in Q3 and 32% YTD; banca NBFC channel grew 27.5% in Q3 and 19% YTD.
- Digital direct channel demonstrates exceptional growth at 70% for Q3 and 49% YTD.
- Tailwinds from GST and awareness campaigns are sustaining healthy volume and value growth, with January trends continuing positively.
2 more points from Niva Bupa Health Insurance Company Ltd's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what Niva Bupa Health Insurance Company Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- No specific mention of current or future capex or strategic capital investments in the provided transcript.
- The discussion primarily focuses on operational aspects such as pricing discipline, claims management, product development, underwriting sophistication, and digital health services.
- Capital-related comments are limited to maintaining a strong solvency ratio (2.49) and alignment of capital allocation to support growth and strengthen return metrics.
- Vishwanath Mahendra highlighted plans for medium-term ROE improvement but did not specify new capital expenditure.
2 more points from Niva Bupa Health Insurance Company Ltd's call on capex
Pro opens every point from 15K+ earnings calls
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Niva Bupa Health Insurance Company Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Niva Bupa Health Insurance Company Ltd's call on order book
Pro opens every point from 15K+ earnings calls
Niva Bupa Health Insurance Company Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹2.1K Cr, net profit ₹345 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Niva Bupa Health Insurance Company Ltd's management said in earlier quarters
Others in Insurance this season
- HDFC Life Insur. (Q3 FY26)
Profit after tax (PAT) grew 7% to Rs. Key concall takeaways from HDFC Life Insurance Company Ltd's Q3 FY26 earnings call — and how it ranks against sector…
- Medi Assist Healthcare Services Ltd (Q3 FY26)
Expansion of technology-led revenue streams, especially from SaaS products like MAtrix and AI-driven solutions such as MAven Guard, with tech revenues growing…
- New India Assurance Company Ltd (Q3 FY26)
Market share is stable or growing in key segments: Fire (17-18%), Marine (18%), and Health/PA (~16.44%). Key concall takeaways from New India Assurance Company…
- Canara HSBC (Q3 FY26)
Annuity business AP grew 34% year-on-year, with focus on deferred annuity for profitable growth. Key concall takeaways from Canara HSBC Life Insurance Company…
Arthneeti Pro · Annual
Niva Bupa Health Insurance Company Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Niva Bupa Health Insurance Company Ltd Q3 FY26 results?
Overall growth in Q3 was 31%, and 26% for the first 9 months, indicating strong upward momentum. The company targets a Return on Equity (ROE) in the high teens within the next two financial years, indicating growth in profitability.
What is Niva Bupa Health Insurance Company Ltd share price analysis?
Niva Bupa Health Insurance Company Ltd currently shows a neutral. The stock trades at a P/E of 92.9 with a market cap of ₹16,188 Cr. Investors should review the full earnings analysis for detailed insights.
Is Niva Bupa Health Insurance Company Ltd planning capital expenditure?
No specific mention of current or future capex or strategic capital investments in the provided transcript.
Keep Niva Bupa Health Insurance Company Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.